-
Media Room Article
Improving Endpoints for Cancer Immunotherapy Clinical Trials
The Cancer Research Institute Cancer Immunotherapy Consortium, the leading global initiative in advancing the emerging field of…
-
Media Room Article
2010 William B. Coley Award Winners to be Honored at CRI’s 24th Annual Awards Dinner in NYC
CRI announced today the three winners of the 2010 William B. Coley Award for Distinguished Research in…
-
Media Room Article
New Cancer Immunotherapy Helps Patients with Metastatic Melanoma Live Longer
A significant new immunotherapy, created by CRI Scientific Advisory Council Associate Director James P. Allison, Ph.D, is…
-
Media Room Article
First FDA Approval of Therapeutic Cancer Vaccine a Milestone Victory for Cancer Immunotherapy
CRI celebrates yesterday’s announcement of the first therapeutic cancer vaccine to receive approval from the U.S. Food…
-
Media Room Article
Scientists Develop Novel Technology to Assess Cancer Vaccine-Induced CD4+ T-cell Response
A team of tumor immunologists in France and Switzerland has established an improved, reliable immune monitoring tool…
-
Media Room Article
2010 Grace Award Winners Announced
CRI announced today that it will present fashion designer Michael Kors and GlaxoSmithKline CEO Andrew Witty with…
-
Media Room Article
CT45, an Unexpected Link Between Hodgkin Lymphoma and Reproductive Germ Cells
In a paper published in the Proceedings of the National Academy of Sciences earlier this month, the…
-
Media Room Article
Targeting Normal Cells in Tumors Slows Cancer Growth
CRI-funded scientists and their colleagues demonstrate that targeting normal cells that surround cancer cells within and around…
-
Media Room Article
Hundreds of Genes Distinguish Patients Likely to Survive Advanced Melanoma
In a recently published paper, researchers led by CRI-funded clinical investigator Dr. Nina Bhardwaj, director of the…
